Baptiste Abbar

Paris, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications

Restarting Immune Checkpoint Inhibitors After ICI Myocarditis: A Prospective Cohort.

Restarting Immune Checkpoint Inhibitors After ICI Myocarditis: A Prospective Cohort.

Journal: Circulation
Published: April 06, 2026

International Consensus on Severe Lung Cancer-The Second Edition.

International Consensus on Severe Lung Cancer-The Second Edition.

Journal: Translational lung cancer research
Published: March 21, 2026

Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.

Real-world efficacy and safety of immune checkpoint blockades in advanced urothelial carcinoma with histologic variant subtypes: the pembroblad study.

Journal: Cancer immunology, immunotherapy : CII
Published: December 11, 2025

CANCERIMMUNE: A new INCa network designed to strengthen expertise in cancers of immunocompromised patients

CANCERIMMUNE: A new INCa network designed to strengthen expertise in cancers of immunocompromised patients

Journal: Bulletin du cancer
Published: December 04, 2025

Response to Letters Regarding "Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors".

Response to Letters Regarding "Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors".

Journal: Clinical pharmacology and therapeutics
Published: October 06, 2025

A Response to the Letter to the Editor: "Re: 'Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC'" by Gokhan Koker and Ozcelik.

A Response to the Letter to the Editor: "Re: 'Human Immunodeficiency Virus Impairs Immune Responses to Tumor Neoepitopes Without Altering Mutational Profiles in NSCLC'" by Gokhan Koker and Ozcelik.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: July 25, 2025

A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategies.

A narrative review of immunotherapy for non-small cell lung cancer: current progress, sensitization approaches, and synergistic strategies.

Journal: Translational lung cancer research
Published: June 27, 2025

Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective study.

Doxorubicin paclitaxel in pretreated advanced small-cell lung cancer: a large real-life retrospective study.

Journal: Translational lung cancer research
Published: June 03, 2025

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis.

Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis.

Journal: Translational lung cancer research
Published: April 10, 2025

Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis.

Vinorelbine With or Without Thiotepa for HER2-Negative Metastatic Breast Cancer: A Propensity Score Analysis.

Journal: Cancer medicine
Published: March 26, 2025

Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)-insights from the TROPiCS-03 trial.

Sacituzumab govitecan: a new hope for patients with pretreated extensive small-cell lung cancer (SCLC)-insights from the TROPiCS-03 trial.

Journal: Translational lung cancer research
Published: February 27, 2025

Rechallenge After Severe Immune Checkpoint Inhibitor Myocarditis: Venturing Into the Unknown.

Rechallenge After Severe Immune Checkpoint Inhibitor Myocarditis: Venturing Into the Unknown.

Journal: JACC. CardioOncology
Published: January 22, 2025
Showing 1-12 of 51

Last Updated: 09/26/2026